Walgreens Appoints Jason Stenta as SVP and Chief Commercial Officer
Walgreens has appointed Jason Stenta as SVP and Chief Commercial Officer, effective early October. In this new role, Stenta will lead the company's B2B commercial growth strategy, focusing on developing and commercializing healthcare services based on Walgreens' core assets. He will also work on enhancing partnerships with payers, health system providers, and life sciences companies.
Stenta brings nearly 20 years of healthcare experience, most recently serving as SVP of payer sales at Optum, a UnitedHealth Group company. Prior to that, he held leadership roles at CVS Health for 10 years. His appointment is expected to strengthen Walgreens' position as a leading community pharmacy and health services provider in the U.S.
Mary Langowski, EVP and president of U.S. Healthcare at Walgreens Boots Alliance, expressed confidence in Stenta's strategic and relationship-driven leadership, highlighting his experience with complex healthcare organizations and understanding of market dynamics, regulatory requirements, and customer needs.
Walgreens ha nominato Jason Stenta come SVP e Chief Commercial Officer, con effetto all'inizio di ottobre. In questo nuovo ruolo, Stenta guiderà la strategia di crescita commerciale B2B dell'azienda, concentrandosi sullo sviluppo e sulla commercializzazione di servizi sanitari basati sui beni fondamentali di Walgreens. Si occuperà anche di migliorare le partnership con i pagatori, i fornitori di sistemi sanitari e le aziende di scienze della vita.
Stenta porta con sé quasi 20 anni di esperienza nel settore della salute, avendo recentemente ricoperto il ruolo di SVP delle vendite ai pagatori in Optum, un'azienda del gruppo UnitedHealth. Prima di questo, ha rivestito ruoli dirigenziali in CVS Health per 10 anni. La sua nomina è prevista per rafforzare la posizione di Walgreens come principale farmacia comunitaria e fornitore di servizi sanitari negli Stati Uniti.
Mary Langowski, EVP e presidente della sanità negli Stati Uniti di Walgreens Boots Alliance, ha espresso fiducia nella leadership strategica e orientata alle relazioni di Stenta, sottolineando la sua esperienza con organizzazioni sanitarie complesse e la comprensione delle dinamiche di mercato, dei requisiti normativi e delle necessità dei clienti.
Walgreens ha nombrado a Jason Stenta como SVP y Director Comercial, con efecto a principios de octubre. En este nuevo rol, Stenta liderará la estrategia de crecimiento comercial B2B de la compañía, enfocándose en desarrollar y comercializar servicios de salud basados en los activos centrales de Walgreens. También trabajará para mejorar las asociaciones con pagadores, proveedores de sistemas de salud y empresas de ciencias de la vida.
Stenta aporta casi 20 años de experiencia en el sector de la salud, habiendo servido recientemente como SVP de ventas a pagadores en Optum, una empresa del grupo UnitedHealth. Antes de eso, ocupó roles de liderazgo en CVS Health durante 10 años. Se espera que su nombramiento fortalezca la posición de Walgreens como una de las principales farmacias comunitarias y proveedor de servicios de salud en EE. UU.
Mary Langowski, EVP y presidenta de Salud en EE. UU. de Walgreens Boots Alliance, expresó confianza en el liderazgo estratégico y orientado a las relaciones de Stenta, destacando su experiencia con organizaciones de salud complejas y su entendimiento de la dinámica del mercado, los requisitos regulatorios y las necesidades de los clientes.
월그린스는 제이슨 스텐타를 SVP이자 최고 상업 책임자로 임명했습니다. 이는 10월 초부터 효력을 발생합니다. 이 새로운 역할에서 스텐타는 회사의 B2B 상업 성장 전략을 이끌고, 월그린스의 핵심 자산을 기반으로 한 헬스케어 서비스를 개발하고 상용화하는 데 집중할 것입니다. 또한 지불자, 건강 시스템 제공업체 및 생명 과학 회사와의 파트너십을 강화하는 작업도 수행할 것입니다.
스텐타는 거의 20년의 헬스케어 경험을 가지고 있으며, 최근에는 유나이티드헬스 그룹의 자회사인 옵텀에서 지불자 판매의 SVP로 재직했습니다. 그 이전에는 CVS 헬스에서 10년 동안 리더십 역할을 맡았습니다. 그의 임명은 월그린스가 미국 내 주요 커뮤니티 약국 및 헬스 서비스 제공자로서의 입지를 강화할 것으로 예상됩니다.
월그린 부츠 얼라이언스의 미주 헬스케어 EVP이자 사장인 메리 랭코우스키는 스텐타의 전략적이고 관계 지향적인 리더십에 대한 신뢰를 표명하며, 복잡한 헬스케어 조직에 대한 그의 경험과 시장 역학, 규제 요건 및 고객 요구에 대한 이해를 강조했습니다.
Walgreens a nommé Jason Stenta au poste de SVP et Directeur Commercial, avec effet début octobre. Dans ce nouveau rôle, Stenta dirigera la stratégie de croissance commerciale B2B de l'entreprise, en se concentrant sur le développement et la commercialisation de services de santé basés sur les actifs essentiels de Walgreens. Il travaillera également à améliorer les partenariats avec les payeurs, les fournisseurs de systèmes de santé et les entreprises de sciences de la vie.
Stenta apporte près de 20 ans d'expérience dans le secteur de la santé, ayant récemment occupé le poste de SVP des ventes aux payeurs chez Optum, une société du groupe UnitedHealth. Avant cela, il a occupé des postes de direction chez CVS Health pendant 10 ans. Sa nomination devrait renforcer la position de Walgreens en tant que pharmacie communautaire de premier plan et fournisseur de services de santé aux États-Unis.
Mary Langowski, EVP et présidente de la Santé aux États-Unis chez Walgreens Boots Alliance, a exprimé sa confiance dans le leadership stratégique et axé sur les relations de Stenta, mettant en avant son expérience avec des organisations de santé complexes et sa compréhension de la dynamique du marché, des exigences réglementaires et des besoins des clients.
Walgreens hat Jason Stenta zum SVP und Chief Commercial Officer ernannt, mit Wirkung ab Anfang Oktober. In dieser neuen Rolle wird Stenta die B2B-Wachstumsstrategie des Unternehmens leiten und sich darauf konzentrieren, Gesundheitsdienstleistungen basierend auf den Kernressourcen von Walgreens zu entwickeln und zu kommerzialisieren. Er wird auch daran arbeiten, die Partnerschaften mit Kostenträgern, Anbietern von Gesundheitssystemen und Unternehmen der Lebenswissenschaften zu verbessern.
Stenta bringt nahezu 20 Jahre Erfahrung im Gesundheitswesen mit, zuletzt war er SVP für Verkauf an Kostenträger bei Optum, einem Unternehmen der UnitedHealth Group. Davor hatte er 10 Jahre Führungspositionen bei CVS Health inne. Seine Ernennung wird voraussichtlich die Position von Walgreens als führende Gemeinschaftsapotheke und Anbieter von Gesundheitsdiensten in den USA stärken.
Mary Langowski, EVP und Präsidentin für das Gesundheitswesen in den USA bei Walgreens Boots Alliance, äußerte Vertrauen in Stentas strategische und beziehungsorientierte Führung und hob seine Erfahrung mit komplexen Gesundheitsorganisationen sowie sein Verständnis für Marktdynamik, regulatorische Anforderungen und Kundenbedürfnisse hervor.
- Appointment of experienced healthcare leader Jason Stenta as SVP and Chief Commercial Officer
- Focus on developing and commercializing B2B healthcare services
- Potential for enhanced partnerships with payers, health system providers, and life sciences companies
- Strengthening Walgreens' position in community pharmacy and health services
- None.
Stenta will lead B2B commercial growth strategy as the company strengthens its role as the first choice for community pharmacy and health services in the
Jason Stenta, SVP & Chief Commercial Officer (Photo: Business Wire)
“Jason is a strategic, relationship-driven healthcare leader, and I’m proud to welcome him to the team,” said Mary Langowski, EVP and president,
Stenta brings nearly 20 years of healthcare experience, successfully leading large organizations and cross-functional teams through growth and change. Most recently, he was at Optum, a UnitedHealth Group company, where he served as SVP, payer sales. Prior to Optum, he held leadership roles at CVS Health for 10 years.
“This is an exciting time at Walgreens, and I’m thrilled to have this unique opportunity to contribute,” said Stenta. “As we look to expand services, and provide partners with healthcare solutions they really need, I believe Walgreens core strengths and services in retail pharmacy will be key in how we’re able to do this.”
Stenta will begin his new role in early October.
About Walgreens
Walgreens (www.walgreens.com) is included in the
View source version on businesswire.com: https://www.businesswire.com/news/home/20241007453700/en/
Morgan Tatum
Morgan.Tatum@walgreens.com
Source: Walgreens
FAQ
Who is the new SVP and Chief Commercial Officer of Walgreens (WBA)?
What will be Jason Stenta's main responsibilities at Walgreens (WBA)?
What is Jason Stenta's professional background before joining Walgreens (WBA)?
When will Jason Stenta start his new role at Walgreens (WBA)?
